| Literature DB >> 32885407 |
Isidro Machado1,2, Francisco Giner3, Javier Lavernia4, Julia Cruz1, Víctor Traves1, Celia Requena5, Beatriz Llombart5, José Antonio López-Guerrero6,7,8, Antonio Llombart-Bosch9.
Abstract
Angiosarcomas (AS) represent a heterogenous group of tumors with variable clinical presentation. AS share an important morphologic and immunohistochemical overlap with other sarcomas, hence the differential diagnosis is challenging, especially in poorly-differentiated tumors. Although molecular studies provide significant clues, especially in the differential diagnosis with other vascular neoplasms, a thorough hematoxylin and eosin analysis remains an essential tool in AS diagnosis. In this review, we discuss pathological and molecular insights with emphasis on implications for differential diagnosis in cutaneous, breast, soft tissue and visceral AS.Entities:
Year: 2020 PMID: 32885407 DOI: 10.14670/HH-18-246
Source DB: PubMed Journal: Histol Histopathol ISSN: 0213-3911 Impact factor: 2.303